Innovent prepares to file GLP-1/glucagon agonist mazdutide in China for diabetes, its second indication after obesity.

Corrections and clarifications: This story has been updated to clarify the charges brought against each of the defendants.

Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases.

President Trump is again amping up his trade threats, unveiling a new batch of letters to country leaders outlining tariffs on goods imported from their countries beginning in August.

Instead of coming out of pocket, you can use your benefits to get deals on glasses. Here are the best places to shop using insurance, FSA, and HSA.